Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
about
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I.JNK, p38, ERK, and SGK1 Inhibitors in Cancer.Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells.
P2860
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@en
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@nl
type
label
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@en
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@nl
prefLabel
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@en
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@nl
P2093
P2860
P1476
Metformin potentiates the effe ...... of p38 MAPK, ERK3, and mTORC1.
@en
P2093
Haiyang Xie
Haojiang Dai
Jianyong Zhuo
Penghong Song
Qiaonan Shan
Shusen Zheng
Xuyong Wei
P2860
P2888
P356
10.1186/S13045-017-0424-0
P50
P577
2017-02-28T00:00:00Z
P6179
1084251884